7-bromo-N-(1-phenylcyclopropyl)-3-((4-piperidin-1-ylpiperidin-1-yl)methyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide,
GSK2193874,
GSK2193874,
1336960-13-4,
GSK 2193874,
GSK-2193874,
CHEMBL4073922,
3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide,
GTPL6465,
SCHEMBL2404540,
BDBM50232797,
s8367,
ZINC98052705,
AKOS024458495,
CS-7612,
NCGC00370767-01,
AK687390,
HY-100720,
A14201,
Q27077882,
GSK2193874GSK-2193874GSK 2193874,
3-(1,4'-Bipiperidin-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide,
7-bromo-N-(1-phenylcyclopropyl)-3-[(4-piperidin-1-ylpiperidin-1-yl) methyl]-2-[3-(trifluoromethyl)phenyl]quinoline-4-carboxamide,
D03LVL,
UIVOZBSCHXCGPS-UHFFFAOYSA-N,
C000628859,
7-bromo-N-(1-phenylcyclopropyl)-3-((4-piperidin-1-ylpiperidin-1-yl)methyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide,